Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Advocacy (policy advocacy, lobbying)
NGO (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Clinical study phase III